85546 Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

BHI EB-TNP Outcome Measurement Report ...................... 27 1 27 5 135 

Total .............................................................................. 27 ........................ 27 ........................ 135 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–24962 Filed 10–25–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Electronic 

Individual Development Plan (eIDP) 

(National Eye Institute) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Dr. Cesar E. Perez-Gonzalez, 

Training Director, Office of the 

Scientific Director, National Eye 

Institute, NIH, Building 31, Room 6A22, 

MSC 0250, Bethesda, Maryland 20892 

or call non-toll-free number (301) 451– 

6763 or Email your request, including 

your address to: cesarp@nei.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on August 1, 2024, 89 FR 62749 

and allowed 60 days for public 

comment. No public comments were 

received. The purpose of this notice is 

to allow an additional 30 days for public 

comment. 

The National Eye Institute (NEI), 

National Institutes of Health, may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: Electronic 

Individual Development Plans, 0925– 

0772 and 10/31/2024-Extension, 

National Eye Institute (NEI), National 

Institutes of Health (NIH). 

Need and Use of Information 

Collection: The National Eye Institute’s 

(NEI) Office of the Scientific Director 

(OSD) goal is to train the next 

generation of vision researchers and 

ophthalmologists. Trainees who 

participate in NEI research come with 

different levels of education (student, 

postbaccalaureate, predoctoral 

including graduate and medical 

students, postdoctoral fellows) and for 

different amounts of time (6 months to 

5 years). Training at the NEI focuses on 

scientific and professional skill 

development. To enhance their chances 

of obtaining their ideal career, 

completing an annual Individual 

Development Plan (IDP) is an important 

step in helping a trainee’s career and 

professional development and is 

standard practice in graduate and 

postdoctoral education. An IDP is an 

effective tool for trainees to think about 

their career goals and skills needed to 

achieve them during their time at the 

NEI. Trainees work together with their 

research mentor to organize and 

summarize their research projects, 

consider career goals, and set training 

goals and expectations, both for the 

mentee and mentor. 

This information collection request is 

to implement an electronic Individual 

Development Plan (eIDP). The data 

collected comes from a detailed 

questionnaire focused on responses to 

professional goals and expectations 

while they are at the NEI. It is expected 

that the trainees will complete the eIDP 

annually and by doing so, it will help 

enhance the effectiveness of their 

training by setting clear goals that can 

be monitored not only by the trainee 

themselves but also by their mentor, the 

Training Director, and their 

Administrative Officer. In addition to 

this eIDP, the system will also 

implement an electronic exit survey. 

The data collected comes from a 

detailed questionnaire focused on 

responses to questions focused on 

trainee mentoring and professional 

experiences at the NEI as well as their 

plans after they depart. It is expected 

that the trainees will complete at the 

end of their tenure and that by doing so, 

the NEI Training Program can learn 

about ways to improve career 

development opportunities for future 

trainees as well as learn more about 

trainee job choices to better advise 

fellows. Additionally, we can use the 

survey to help determine mentor 

effectiveness and help identify problems 

in mentoring at the NEI. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

213. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices 85547 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of 

respondent 

Number of 

respondents 

Number of 

responses per 

respondent 

Average 

time per 

response 

(in hours) 

Total 

annual 

burden 

hour 

eIDP (Attachment 1) ................................................................ Individuals .............. 150 1 1 150 

Exit Survey Part 1 (Attachment 2) .......................................... Individuals .............. 150 1 5/60 13 

Exit Survey Part 2 (Attachment 3) .......................................... Individuals .............. 150 1 20/60 50 

Total .................................................................................. ................................ ...................... 450 ...................... 213 

Dated: October 23, 2024. 

Cesar E. Perez-Gonzalez, 

Training Director, National Eye Institute, 

National Institutes of Health. 

[FR Doc. 2024–25017 Filed 10–25–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01 Clinical 

Trial Not Allowed). 

Date: November 21, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G34, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Vishakha Sharma, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G34, Rockville, MD 

20892, 301–761–7036, vishakha.sharma@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 22, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–24975 Filed 10–25–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel: Tailoring HIV Curative 

Strategies to the Participant (UM1 Clinical 

Trial Not Allowed). 

Date: December 2–3, 2024. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G22 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Kristina S. Wickham, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G22, 

Rockville, MD 20892, 301–761–5390, 

kristina.wickham@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 22, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–24980 Filed 10–25–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 

Implementation Cooperative Agreement (U01 

Clinical Trial Required). 

Date: November 19, 2024. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Barry J. Margulies, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 


lotter on DSK11XQN23PROD with NOTICES1